POS-068 DIAGNOSTIC VALUE OF PLASMA NEUTROPHIL GELATINASE - ASSOCIATED LIPOCALIN (NGAL) IN DISTINGUISHING ACUTE KIDNEY INJURY FROM CHRONIC KIDNEY DISEASE
Salman Reza, Prodip Kumar Dutta
Abstract
Salman Reza, Prodip Kumar Dutta
Abstract
Acute kidney injury (AKI) and chronic kidney disease (CKD) are conditions that substantially increase morbidity and mortality. New biomarker plasma neutrophil gelatinase –associated lipocalin (NGAL) can identify the patients with AKI and CKD earlier which helps to intervene and modify outcome.The aim of the study was to determine whether plasma NGAL levels could be used to distinguish AKI and CKD.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Acute kidney injury (AKI) and chronic kidney disease (CKD) are conditions that substantially increase morbidity and mortality. New biomarker plasma neutrophil gelatinase –associated lipocalin (NGAL) can identify the patients with AKI and CKD earlier which helps to intervene and modify outcome.The aim of the study was to determine whether plasma NGAL levels could be used to distinguish AKI and CKD.
Key concepts: Medicine, Lipocalin, Acute kidney injury, Kidney disease, Neutrophil gelatinase-associated lipocalin, Biomarker, Internal medicine, Kidney